NCT02697214

Brief Summary

Over the last two decades, there has been a proliferation of commercially available heart rate monitors. Recognizing that elite athletes often use heart rate to monitor training and assess aerobic fitness, fitness companies have offered a variety of heart rate monitoring systems to the general public. Recently, there has been a move from monitors that rely on chest straps to measure electrical activity toward more convenient, wrist-worn monitors that employ optical sensing technology similar to that used for pulse oximetry. While the accuracy of chest strap monitors has been assessed in a variety of studies, there is no data concerning the accuracy of wrist-worn heart rate monitors. Assessment of the monitors' accuracy is important both for the subjects who rely upon these monitors to guide their athletic activity and for the physicians to whom these individuals report their heart rate readings.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P50-P75 for not_applicable healthy

Timeline
Completed

Started Aug 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 24, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 3, 2016

Completed
2.9 years until next milestone

Results Posted

Study results publicly available

February 11, 2019

Completed
Last Updated

February 11, 2019

Status Verified

February 1, 2019

Enrollment Period

5 months

First QC Date

February 24, 2016

Results QC Date

December 13, 2016

Last Update Submit

February 4, 2019

Conditions

Keywords

commercial heart rate monitorsaccuracyECGvarying degrees of exertion

Outcome Measures

Primary Outcomes (1)

  • Measuring the Accuracy of Commercial Heart Rate Monitors.

    The purpose of this study is to assess the accuracy of four popular, commercially available wrist-worn heart rate monitors compared to the current gold standard of a ECG using Lin's Concordance Correlation Coefficient.

    20 minutes

Study Arms (4)

Apple Watch

ACTIVE COMPARATOR

Apple Watch heart rate monitoring device worn with standard ECG, Polar H7 chest monitor and one other wrist monitoring device .

Device: Apple Watch

Fitbit Charge HR

ACTIVE COMPARATOR

Fitbit Charge HR heart rate monitoring device worn with standard ECG, Polar H7 chest monitor and one other wrist monitoring device.

Device: Fitbit Charge HR

Mio Fuse

ACTIVE COMPARATOR

Mio Fuse heart rate monitoring device worn with standard ECG, Polar H7 chest monitor and one other wrist monitoring device.

Device: Mio Fuse

Basis Peak

ACTIVE COMPARATOR

Basis Peak heart rate monitoring device worn with standard ECG, Polar H7 chest monitor and one other wrist monitoring device.

Device: Basis Peak

Interventions

Fitbit Charge HR heart rate monitoring device compared to ECG and Polar H7

Fitbit Charge HR

Apple Watch heart rate monitoring device compared to ECG and Polar H7

Apple Watch
Mio FuseDEVICE

Mio Fuse heart rate monitoring device compared to ECG and Polar H7

Mio Fuse

Basis Peak heart rate monitoring device compared to ECG and Polar H7

Basis Peak

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years
  • Able and willing to exercise (walk/jog) for a total of fifteen minutes

You may not qualify if:

  • Health issues that preclude or contraindicate walking and/or jogging, including cardiovascular, orthopedic, pulmonary and other conditions
  • Presence of a cardiac pacemaker
  • Known cardiovascular disease
  • Known heart rhythm disorders
  • Use of Beta-blockers or antiarrhythmic medications
  • Tattoos around the wrist area

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Results Point of Contact

Title
Marc Gillinov, MD
Organization
The Cleveland Clinic

Study Officials

  • Marc Gillinov, MD

    The Cleveland Clinic

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

February 24, 2016

First Posted

March 3, 2016

Study Start

August 1, 2015

Primary Completion

January 1, 2016

Study Completion

January 1, 2016

Last Updated

February 11, 2019

Results First Posted

February 11, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share